OLD Category: Oncology

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients

• Marcucci G et al.,

FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells

• Manoranjan B. et al.,

Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases

• Zhuang G. et al.,

TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

• Sakuishi K. et al.,

Genomic impact of transient low-dose decitabine treatment on primary AML cells

• Klco J.M. et al.,

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

• Reipas K.M. et al.,

Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

• Hudson R.S. et al.,

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

• Morgan R.A. et al.,

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

• Cascione L. et al.,

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

• Bhola N. E. et al.,

A 13-Gene Signature Prognostic of HPV-Negative OSCC: Discovery and External Validation

• Lohavanichbutr P. et al.,

Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation

• Stricker T.P. et al.,